全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Evaluation of Azithromycin As Add On Therapy in Community Acquired Pneumonia Patients; A Pilot Clinical Study

Keywords: Add on therapy , Azithromycin , Community Acquired Pneumonia , Duration of hospitalization.

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective: The objective of this pilot clinical study was evaluation of efficacy and safety of azithromycin versus placebo in combination with standard antibiotic therapy in Community acquired Pneumonia (CAP) patients.Materials & Methods: Effectiveness of azithromycin was evaluated at dose 500 mg orally once in a day, for ten days with standard antibiotic therapy cefotaxim 500mg i.v. (t.i.d.) in adult patients who hospitalized for CAP. We selected n = 40 patients and randomized into two groups azithromycin and placebo. We analyzed the effectiveness of concomitant use of azithromycin in CAP patients on the basis of improvement in clinical characteristics, duration of hospitalization and outcomes.Result; On comparison with the standard therapy, CAP patients who received azithromycin tablet showed a significant reduction in average length of stay in the hospital (Mean ± SD) days for study group and controls, mortality and clinical outcomes. However moderate improvement was observed in clinical characteristics (reduction in Pneumonia scores of study group versus controls) with standard therapy of CAP treatment.Conclusion: Concomitant administration of azithromycin showed significant benefits in reduction in length of hospital stay and mortality rate when added to standard care. This benefit is independent of its antibiotic activity.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133